Short Communications 27
Schizophrenia 3 - Clinical (3)

[SC27-3] CYP2D6 genotypes and treatment failure with risperidone or aripiprazole: results from a one-year longitudinal study

*Chin B Eap¹, Setareh Ranjbar², Franziska Gamma³, Kerstin von Plessen⁴, Armin von Gunten⁵, Philippe Conus⁶, Cecile Gras¹, Marianna Piras¹ (1. Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neurosciences, Hospital of Cery, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, 2. Psychiatric Epidemiology and Psychopathology Research Center, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland, 3. Les Toises Psychiatry and Psychotherapy Center, Lausanne, Switzerland, 4. Service of Child and Adolescent Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland, 5. Service of Old Age Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland, 6. Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland.)

Keywords:antipsychotics, pharmacogenetics, phenoconversion